Barclays' analyst team cut its price target for Wix.com to $155 and kept an Overweight rating, citing bookings growth as a key driver.
The adjustment signals to investors that the London‑based bank sees stronger customer acquisition as central to Wix's revenue outlook, potentially influencing trading activity.
Barclays' analyst team, which covers the company in its global equity research unit in London, said in a note released on April 9[1] that Wix.com’s bookings—new contracts signed by customers—have been expanding at a pace that could outstrip prior forecasts.
The bank lowered its price target from $160 to $155[2] and kept an Overweight rating[2]. An Overweight stance means Barclays expects the stock to outperform the broader market, a view that may attract institutional buyers.
Management’s focus on empowering creators and small businesses, combined with higher‑margin subscription tiers, underpins the bookings growth the analysts cited. Barclays projects that this trend will lift Wix’s revenue and earnings throughout 2026 and beyond.
Investors have already responded, with Wix.com shares gaining roughly 3% in after‑hours trading following the release[1]. The adjustment also puts the stock closer to its new target, narrowing the upside potential perceived by traders.
**What this means** Barclays’ revised target suggests it believes Wix.com’s growth trajectory is solid enough to justify a modest price reduction while still expecting outperformance. The emphasis on bookings indicates that future earnings will hinge on the company’s ability to attract and retain paying customers, a factor that could shape analyst sentiment and investor demand in the coming quarters.
“Barclays lowered its price target from $160 to $155.”
Barclays’ revised target suggests it believes Wix.com’s growth trajectory is solid enough to justify a modest price reduction while still expecting outperformance. The emphasis on bookings indicates that future earnings will hinge on the company’s ability to attract and retain paying customers, a factor that could shape analyst sentiment and investor demand in the coming quarters.




